These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9141972)

  • 1. Reversible severe hereditary hemochromatotic cardiomyopathy.
    Madani TA; Bormanis J
    Can J Cardiol; 1997 Apr; 13(4):391-4. PubMed ID: 9141972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemochromatosis (hereditary, "primary" hemochromatosis)].
    Krayenbühl P; Naumann UK; Käser L; Vetter W
    Praxis (Bern 1994); 2007 Dec; 96(51-52):2029-35; quiz 2036-7. PubMed ID: 18217648
    [No Abstract]   [Full Text] [Related]  

  • 3. [-Cardiomyopathy as the cause of death in genetic hemochromatosis-].
    von Herbay A; Niederau C; Pilichowska M; Reinecke P; Perings C; Vester E; Strohmeyer G; Häussinger D
    Z Gastroenterol; 1996 Mar; 34(3):178-82. PubMed ID: 8650971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical findings and therapy of classical hereditary haemochromatosis (type 1)].
    Niederau C
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S207-8. PubMed ID: 16435710
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis].
    Spraul CW; Schicketanz C; Lang GE
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):31-6. PubMed ID: 8965474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinically isolated cardiac hemochromatosis treated with success by desferrioxamine].
    Moretti G; Staeffen J; Galley P; Mulet M; Descamps F
    J Med Bord; 1965 Dec; 142(12):1983-6. PubMed ID: 5855516
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term intraperitoneal deferoxamine for hemochromatosis.
    Swartz RD; Legault DJ
    Am J Med; 1996 Mar; 100(3):308-12. PubMed ID: 8629676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical and surgical treatment of neonatal hemochromatosis: single center experience.
    Heffron T; Pillen T; Welch D; Asolati M; Smallwood G; Hagedorn P; Fasola C; Solis D; Rodrigues J; DePaolo J; Spivey J; Martinez E; Henry S; Romero R
    Pediatr Transplant; 2007 Jun; 11(4):374-8. PubMed ID: 17493216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary hemachromatosis: clinical case report and literature review].
    Prochazka R; Tagle M
    Rev Gastroenterol Peru; 2006; 26(3):312-7. PubMed ID: 17053826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardiopathy caused by iron deposition. Treatment with chelating agents].
    Rodríguez Reguero JJ; Iglesias Cubero G; Espolita Santos A; López de la Iglesia JM; Enríquez Martín J; Tomás Mauri J; López-Negrete L
    Rev Esp Cardiol; 1985; 38(5):356-7. PubMed ID: 4081244
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparing Care of the Primary and Secondary Hemochromatosis Patients.
    Becker S
    J Infus Nurs; 2020; 43(2):65-69. PubMed ID: 32106193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary hemocromatosis].
    Franchini M; Veneri D
    Recenti Prog Med; 2004 Oct; 95(10):457-62. PubMed ID: 15560291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial hemochromatotic cardiomyopathy].
    Almazán Ceballos A; Rubio Sanz R; Molinero Somolinos F; Falzgraf Taylor S; Rodríguez Costa J
    Med Clin (Barc); 1983 Apr; 80(11):499-501. PubMed ID: 6865527
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible cardiomyopathy associated with hemochromatosis.
    Easley RM; Schreiner BF; Yu PN
    N Engl J Med; 1972 Oct; 287(17):866-7. PubMed ID: 5071966
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of hereditary hemochromatosis with predominant involvement of the heart].
    Enikeeva NB; Shcherbinina SP; Tarasov VK; Savel'eva TV; Moiseev SV; Severov MV; Levina AA; Klinova EG; Nushtaeva NN; Anikina TP
    Ter Arkh; 1991; 63(4):137-9. PubMed ID: 2068666
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
    Hicken BL; Tucker DC; Barton JC
    Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary hemochromatosis.
    Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
    Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac hemochromatosis.
    Templin C; Pertschy S; Schaefer A
    Int J Cardiol; 2007 Apr; 116(3):e109-10. PubMed ID: 17134777
    [No Abstract]   [Full Text] [Related]  

  • 19. In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy.
    Muncunill J; Vaquer P; Galmés A; Obrador A; Parera M; Bargay J; Besalduch J
    J Clin Apher; 2002; 17(2):88-92. PubMed ID: 12210712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary hemochromatosis: when do we treat it?].
    Niederau C
    Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1622. PubMed ID: 16823716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.